查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
类器官服务市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用、来源和地理位置
市场调查报告书
商品编码
1558383

类器官服务市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按类型、应用、来源和地理位置

Organoids Services Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, and Geography
出版日期: | 出版商: The Insight Partners | 英文 168 Pages | 订单完成后即时交付

价格

根据我们关于「2031 年类器官服务市场预测 - 全球分析 - 按类型、应用、来源和地理位置」的新研究，该市场预计将从 2023 年的 30.3 亿美元增长到 15.01 美元到2031 年将达到10亿；预计 2023-2031 年复合年增长率为 22.3%。促进类器官服务市场成长的因素包括对新型药物筛选服务的需求不断增长，以及定製药物的普及。然而，缺乏熟练的专业人员和严格的安全法规阻碍了市场的成长。

类器官是基于细胞的简单组织工程体外模型，概括了相应体内组织复杂结构和功能的许多方面。它们可以被解剖和询问，用于人体组织发育、再生和修復的基本机制研究，也可以用于诊断、疾病建模、药物发现和个人化医疗。

北美主导着类器官服务市场。美国的市场参与者正专注于有机成长策略以巩固自己的立足点。 2023 年 2 月，Molecular Devices, LLC。和 HUB Organoids (HUB) 宣布开展策略合作，继续开发下一代 3D 生物学技术，推动临床前到临床药物损耗的逐步减少。此外，不断增加的研究和开发活动、对组织工程和器官移植的需求不断增长以及类器官的高采用率正在推动该国的类器官服务市场。类器官有潜力克服先前与生物医学研究相关的几个局限性，重点关注为研究人员提供有关人类发育的机制见解，产生准确的人类疾病模型，并为再生医学产生与患者匹配的组织来源。预计亚太地区 2023 年至 2031 年复合年增长率最高。

加大重点开发力度，为未来提供市场机会

医疗保健产业的进步导致全球对类器官的需求增加。这种需求的增加有助于全球范围内的新产品开发、收购、合作、产品发布和批准。主要市场参与者参与活动，以确保高效服务和产品的创新和开发。以下列出了最近的一些关键进展：

2024 年 6 月，Molecular Devices, LLC。其在英国卡迪夫的专用工厂正式开幕。这座耗资数百万英镑的设施旨在适应该业务的独特生物工艺流程和创新生物反应器技术，从而实现 PDO 的大规模、品质控制生产。大量 3D 就绪的可重复 PDO 可作为客製化服务提供，并以可用于分析的方式冷冻保存。研究人员可以根据需要解冻、电镀和使用这些产品。

2024年5月，生技公司InSphero与法兰克福Genome Biologics签署了合作协议。透过此次合作，InSphero 将获得 Genome Biologics 3D 心臟类器官平台商业化的全球专属权利。该平台提供准确、可扩展且针对特定疾病的类器官模型，用于创建新的治疗方法，使其处于心臟病研究的前沿。

2023 年 7 月，Molecular Devices 推出了客製化类器官产品线扩展服务，采用独特的生物製程技术，适用于高通量应用。

2023 年 2 月，Molecular Devices, LLC. 和 HUB Organoids (HUB) 宣布开展策略合作，共同致力于下一代 3D 生物技术的持续开发，从而逐步减少临床前到临床的药物损耗。

2022 年 12 月，Molecular Devices, LLC。收购了 Cellesce Ltd。

2021年8月，STEMCELL Technologies与Hubrecht Organoid Technology (HUB)签署协议。作为该协议的一部分，STEMCELL 的合约检测服务部门开始向 HUB 提供其组织源类器官，例如肺、肠和肝臟类器官，用于临床前毒理学筛检和非癌症药物开发服务。这些服务将促进研究人员和药物开发组织将类器官整合到临床前测试计画中，以帮助更快、更经济地推出新疗法。

市场参与者之间的此类关键开发、发布和策略合作为类器官服务市场的成长创造了充足的机会。

基于应用程式的见解

按应用划分，市场分为发育生物学、传染病病理学、再生医学、药物毒性和功效测试、药物发现和个人化医疗等。 2023年，发育生物学疾病领域占最大市场份额；预计 2023 年至 2031 年复合年增长率将达到最高。

基于来源的见解

根据来源，类器官服务市场分为多能干细胞和器官特异性成体干细胞。到 2023 年，多能干细胞细分市场将占据更大的市场份额。

类器官服务市场：竞争格局与主要发展

中华生物製药股份有限公司； Eurofins Scientific SE；分子器件有限责任公司； InSphero；赛普勒斯;创新服务；实验室；库萨比奥科技有限责任公司；肿瘤设计服务；和 HUB Organoids BV（Hubrecht Organoid Technology）是类器官服务市场上的主要公司之一。

美国食品药物管理局、疾病管制与预防中心 (CDC) 和全球疾病负担研究是准备类器官服务市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：类器官服务市场格局

  • PEST分析

第 5 章：类器官服务市场 - 主要市场动态

  • 类器官服务市场 - 主要市场动态
  • 市场驱动因素
    • 创新药物筛选服务的需求不断增加
    • 个人化药物的受欢迎程度激增
  • 市场限制
    • 缺乏熟练的专业人员
  • 市场机会
    • 增加关键发展
  • 未来趋势
    • 人工智慧整合
  • 驱动因素和限制的影响：

第 6 章：类器官服务市场 - 全球市场分析

  • 类器官服务市场收入，2021-2031
  • 类器官服务市场预测分析

第 7 章：类器官服务市场分析 - 按类型

  • 肠
  • 肝
  • 胃
  • 胰臟
  • 肺
  • 脑
  • 肾
  • 其他的

第 8 章：类器官服务市场分析 - 按应用

  • 发育生物学疾病
  • 传染病病理学
  • 再生医学
  • 药物毒性和药效测试
  • 药物发现与个人化医疗
  • 其他的

第 9 章：类器官服务市场分析 - 按来源

  • 多能干细胞
  • 器官特异性成体干细胞

第 10 章：类器官服务市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：产业格局

  • 概述
  • 类器官服务市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Sino Biological Inc.
  • Eurofins Scientific SE
  • Molecular Devices, LLC.
  • InSphero
  • Cyprio
  • InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B.V. (Hubrecht Organoid Technology)

第 13 章：附录

Product Code: TIPRE00039302

According to our new research study on "Organoids Services Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.3% during 2023-2031. Factors contributing to the organoids services market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.

Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.

North America dominates the organoids services market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.

Increasing Key Developments to Provide Market Opportunities in Future

The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:

In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.

In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.

In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.

In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.

In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.

In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.

Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid services market growth..

Application -Based Insights

By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.

Source -Based Insights

Based on source, the organoids services market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.

Organoids services Market: Competitive Landscape and Key Developments

Sino Biological Inc.; Eurofins Scientific SE; Molecular Devices, LLC.; InSphero; Cyprio; InnoSer; LABTOO; CUSABIO TECHNOLOGY LLC; Oncodesign Services; and HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids services market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids services market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Organoids Services Market Landscape

  • 4.1 PEST Analysis

5. Organoids Services Market - Key Market Dynamics

  • 5.1 Organoids Services Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Demand for Innovative Drug Screening Services
    • 5.2.2 Surge in Popularity of Personalized Drugs
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Professionals
  • 5.4 Market Opportunities
    • 5.4.1 Increasing Key Developments
  • 5.5 Future Trends
    • 5.5.1 Integration of Artificial Intelligence
  • 5.6 Impact of Drivers and Restraints:

6. Organoids Services Market - Global Market Analysis

  • 6.1 Organoids Services Market Revenue (US$ Million), 2021-2031
  • 6.2 Organoids Services Market Forecast Analysis

7. Organoids Services Market Analysis - by Type

  • 7.1 Intestine
    • 7.1.1 Overview
    • 7.1.2 Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview
    • 7.2.2 Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Stomach
    • 7.3.1 Overview
    • 7.3.2 Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Pancreas
    • 7.4.1 Overview
    • 7.4.2 Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Lung
    • 7.5.1 Overview
    • 7.5.2 Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Brain
    • 7.6.1 Overview
    • 7.6.2 Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Kidney
    • 7.7.1 Overview
    • 7.7.2 Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Services Market Analysis - by Application

  • 8.1 Developmental Biology Disease
    • 8.1.1 Overview
    • 8.1.2 Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease
    • 8.2.1 Overview
    • 8.2.2 Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine
    • 8.3.1 Overview
    • 8.3.2 Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine
    • 8.5.1 Overview
    • 8.5.2 Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Services Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview
    • 9.1.2 Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Organ Specific Adult Stem Cell
    • 9.2.1 Overview
    • 9.2.2 Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Services Market - Geographical Analysis

  • 10.1 Overview
  • 10.2 North America
    • 10.2.1 North America Organoids Services Market Overview
    • 10.2.2 North America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.2.3 North America: Organoids Services Market Breakdown, by Type
      • 10.2.3.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.2.4 North America: Organoids Services Market Breakdown, by Application
      • 10.2.4.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.2.5 North America: Organoids Services Market Breakdown, by Source
      • 10.2.5.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.2.6 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.1 North America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.2.6.2 United States: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.2.1 United States: Organoids Services Market Breakdown, by Type
        • 10.2.6.2.2 United States: Organoids Services Market Breakdown, by Application
        • 10.2.6.2.3 United States: Organoids Services Market Breakdown, by Source
      • 10.2.6.3 Canada: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.3.1 Canada: Organoids Services Market Breakdown, by Type
        • 10.2.6.3.2 Canada: Organoids Services Market Breakdown, by Application
        • 10.2.6.3.3 Canada: Organoids Services Market Breakdown, by Source
      • 10.2.6.4 Mexico: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.2.6.4.1 Mexico: Organoids Services Market Breakdown, by Type
        • 10.2.6.4.2 Mexico: Organoids Services Market Breakdown, by Application
        • 10.2.6.4.3 Mexico: Organoids Services Market Breakdown, by Source
  • 10.3 Europe
    • 10.3.1 Europe Organoids Services Market Overview
    • 10.3.2 Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.3.3 Europe: Organoids Services Market Breakdown, by Type
      • 10.3.3.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.3.4 Europe: Organoids Services Market Breakdown, by Application
      • 10.3.4.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.3.5 Europe: Organoids Services Market Breakdown, by Source
      • 10.3.5.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.3.6 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.1 Europe: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.3.6.2 Germany: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.2.1 Germany: Organoids Services Market Breakdown, by Type
        • 10.3.6.2.2 Germany: Organoids Services Market Breakdown, by Application
        • 10.3.6.2.3 Germany: Organoids Services Market Breakdown, by Source
      • 10.3.6.3 United Kingdom: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.3.1 United Kingdom: Organoids Services Market Breakdown, by Type
        • 10.3.6.3.2 United Kingdom: Organoids Services Market Breakdown, by Application
        • 10.3.6.3.3 United Kingdom: Organoids Services Market Breakdown, by Source
      • 10.3.6.4 France: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.4.1 France: Organoids Services Market Breakdown, by Type
        • 10.3.6.4.2 France: Organoids Services Market Breakdown, by Application
        • 10.3.6.4.3 France: Organoids Services Market Breakdown, by Source
      • 10.3.6.5 Italy: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.5.1 Italy: Organoids Services Market Breakdown, by Type
        • 10.3.6.5.2 Italy: Organoids Services Market Breakdown, by Application
        • 10.3.6.5.3 Italy: Organoids Services Market Breakdown, by Source
      • 10.3.6.6 Spain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.6.1 Spain: Organoids Services Market Breakdown, by Type
        • 10.3.6.6.2 Spain: Organoids Services Market Breakdown, by Application
        • 10.3.6.6.3 Spain: Organoids Services Market Breakdown, by Source
      • 10.3.6.7 Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.3.6.7.1 Rest of Europe: Organoids Services Market Breakdown, by Type
        • 10.3.6.7.2 Rest of Europe: Organoids Services Market Breakdown, by Application
        • 10.3.6.7.3 Rest of Europe: Organoids Services Market Breakdown, by Source
  • 10.4 Asia Pacific
    • 10.4.1 Asia Pacific Organoids Services Market Overview
    • 10.4.2 Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.4.3 Asia Pacific: Organoids Services Market Breakdown, by Type
      • 10.4.3.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.4.4 Asia Pacific: Organoids Services Market Breakdown, by Application
      • 10.4.4.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.4.5 Asia Pacific: Organoids Services Market Breakdown, by Source
      • 10.4.5.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.4.6 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.1 Asia Pacific: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.4.6.2 Japan: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.2.1 Japan: Organoids Services Market Breakdown, by Type
        • 10.4.6.2.2 Japan: Organoids Services Market Breakdown, by Application
        • 10.4.6.2.3 Japan: Organoids Services Market Breakdown, by Source
      • 10.4.6.3 China: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.3.1 China: Organoids Services Market Breakdown, by Type
        • 10.4.6.3.2 China: Organoids Services Market Breakdown, by Application
        • 10.4.6.3.3 China: Organoids Services Market Breakdown, by Source
      • 10.4.6.4 India: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.4.1 India: Organoids Services Market Breakdown, by Type
        • 10.4.6.4.2 India: Organoids Services Market Breakdown, by Application
        • 10.4.6.4.3 India: Organoids Services Market Breakdown, by Source
      • 10.4.6.5 South Korea: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.5.1 South Korea: Organoids Services Market Breakdown, by Type
        • 10.4.6.5.2 South Korea: Organoids Services Market Breakdown, by Application
        • 10.4.6.5.3 South Korea: Organoids Services Market Breakdown, by Source
      • 10.4.6.6 Australia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.6.1 Australia: Organoids Services Market Breakdown, by Type
        • 10.4.6.6.2 Australia: Organoids Services Market Breakdown, by Application
        • 10.4.6.6.3 Australia: Organoids Services Market Breakdown, by Source
      • 10.4.6.7 Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.4.6.7.1 Rest of APAC: Organoids Services Market Breakdown, by Type
        • 10.4.6.7.2 Rest of APAC: Organoids Services Market Breakdown, by Application
        • 10.4.6.7.3 Rest of APAC: Organoids Services Market Breakdown, by Source
  • 10.5 Middle East and Africa
    • 10.5.1 Middle East and Africa Organoids Services Market Overview
    • 10.5.2 Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.5.3 Middle East and Africa: Organoids Services Market Breakdown, by Type
      • 10.5.3.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.5.4 Middle East and Africa: Organoids Services Market Breakdown, by Application
      • 10.5.4.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.5.5 Middle East and Africa: Organoids Services Market Breakdown, by Source
      • 10.5.5.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.5.6 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.1 Middle East and Africa: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.5.6.2 Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.2.1 Saudi Arabia: Organoids Services Market Breakdown, by Type
        • 10.5.6.2.2 Saudi Arabia: Organoids Services Market Breakdown, by Application
        • 10.5.6.2.3 Saudi Arabia: Organoids Services Market Breakdown, by Source
      • 10.5.6.3 South Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.3.1 South Africa: Organoids Services Market Breakdown, by Type
        • 10.5.6.3.2 South Africa: Organoids Services Market Breakdown, by Application
        • 10.5.6.3.3 South Africa: Organoids Services Market Breakdown, by Source
      • 10.5.6.4 United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.4.1 United Arab Emirates: Organoids Services Market Breakdown, by Type
        • 10.5.6.4.2 United Arab Emirates: Organoids Services Market Breakdown, by Application
        • 10.5.6.4.3 United Arab Emirates: Organoids Services Market Breakdown, by Source
      • 10.5.6.5 Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.5.6.5.1 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Type
        • 10.5.6.5.2 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Application
        • 10.5.6.5.3 Rest of Middle East and Africa: Organoids Services Market Breakdown, by Source
  • 10.6 South and Central America
    • 10.6.1 South and Central America Organoids Services Market Overview
    • 10.6.2 South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
    • 10.6.3 South and Central America: Organoids Services Market Breakdown, by Type
      • 10.6.3.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Type
    • 10.6.4 South and Central America: Organoids Services Market Breakdown, by Application
      • 10.6.4.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Application
    • 10.6.5 South and Central America: Organoids Services Market Breakdown, by Source
      • 10.6.5.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Source
    • 10.6.6 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.1 South and Central America: Organoids Services Market - Revenue and Forecast Analysis - by Country
      • 10.6.6.2 Brazil: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.2.1 Brazil: Organoids Services Market Breakdown, by Type
        • 10.6.6.2.2 Brazil: Organoids Services Market Breakdown, by Application
        • 10.6.6.2.3 Brazil: Organoids Services Market Breakdown, by Source
      • 10.6.6.3 Argentina: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.3.1 Argentina: Organoids Services Market Breakdown, by Type
        • 10.6.6.3.2 Argentina: Organoids Services Market Breakdown, by Application
        • 10.6.6.3.3 Argentina: Organoids Services Market Breakdown, by Source
      • 10.6.6.4 Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
        • 10.6.6.4.1 Rest of South and Central America: Organoids Services Market Breakdown, by Type
        • 10.6.6.4.2 Rest of South and Central America: Organoids Services Market Breakdown, by Application
        • 10.6.6.4.3 Rest of South and Central America: Organoids Services Market Breakdown, by Source

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Organoids Services Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Sino Biological Inc.
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Eurofins Scientific SE
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Molecular Devices, LLC.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 InSphero
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Cyprio
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 InnoSer
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 LABTOO
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 CUSABIO TECHNOLOGY LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Oncodesign Services
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Organoids Services Market Segmentation
  • Table 2. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Organoids Services Market - Revenue and Forecast to 2031 (US$ Million) - by Source
  • Table 6. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 7. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 8. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 9. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 10. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 11. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 12. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 13. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 14. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 15. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 16. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 17. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 19. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 20. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 21. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 22. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 23. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 24. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 26. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 27. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 28. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 29. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 30. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 31. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 32. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 35. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 36. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 37. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 38. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 39. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 40. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 41. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 42. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 43. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 45. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 46. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 47. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 48. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 49. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 52. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 53. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 54. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 55. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 56. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 57. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 58. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 59. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 60. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 63. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 64. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 65. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 66. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 67. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 68. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 69. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 70. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 71. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 72. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 73. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 74. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 75. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 76. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 77. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 79. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 80. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 81. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 82. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 83. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 84. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 85. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 86. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 87. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 88. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 89. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 91. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 92. Recent Organic Growth Strategies in Organoids Services Market
  • Table 93. Recent Inorganic Growth Strategies in the Organoids Services Market
  • Table 94. Glossary of Terms, Organoids Services Market

List Of Figures

  • Figure 1. Organoids Services Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organoids Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Organoids Services Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Liver: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Stomach: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Pancreas: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Lung: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Brain: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Kidney: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organoids Services Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Organoids Services Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Organ Specific Adult Stem Cell: Organoids Services Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Organoids Services Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 25. North America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. North America: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 27. North America: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 28. North America: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 29. North America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 30. United States: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Canada: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Mexico: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Europe: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 35. Europe: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 36. Europe: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 37. Europe: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 38. Germany: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. United Kingdom: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. France: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Italy: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Spain: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. Rest of Europe: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. Asia Pacific: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Asia Pacific: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 46. Asia Pacific: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 47. Asia Pacific: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 48. Asia Pacific: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 49. Japan: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. China: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. India: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. South Korea: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. Australia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. Rest of APAC: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Middle East and Africa: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 57. Middle East and Africa: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 58. Middle East and Africa: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 59. Middle East and Africa: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 60. Saudi Arabia: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. South Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. United Arab Emirates: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. Rest of Middle East and Africa: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 64. South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 65. South and Central America: Organoids Services Market Breakdown, by Type (2023 and 2031)
  • Figure 66. South and Central America: Organoids Services Market Breakdown, by Application (2023 and 2031)
  • Figure 67. South and Central America: Organoids Services Market Breakdown, by Source (2023 and 2031)
  • Figure 68. South and Central America: Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 69. Brazil: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 70. Argentina: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 71. Rest of South and Central America: Organoids Services Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. Growth Strategies in Organoids Services Market